Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 8 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 21 |
NetGPI | no | yes: 0, no: 21 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0031974 | membrane-enclosed lumen | 2 | 1 |
GO:0031981 | nuclear lumen | 5 | 1 |
GO:0032838 | plasma membrane bounded cell projection cytoplasm | 4 | 1 |
GO:0043233 | organelle lumen | 3 | 1 |
GO:0070013 | intracellular organelle lumen | 4 | 1 |
GO:0097014 | ciliary plasm | 5 | 1 |
GO:0099568 | cytoplasmic region | 3 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: E8NHQ8
Term | Name | Level | Count |
---|---|---|---|
GO:0006082 | organic acid metabolic process | 3 | 3 |
GO:0006520 | amino acid metabolic process | 3 | 3 |
GO:0006573 | valine metabolic process | 5 | 3 |
GO:0006574 | valine catabolic process | 6 | 3 |
GO:0006807 | nitrogen compound metabolic process | 2 | 3 |
GO:0008152 | metabolic process | 1 | 3 |
GO:0009056 | catabolic process | 2 | 3 |
GO:0009063 | amino acid catabolic process | 4 | 3 |
GO:0009081 | branched-chain amino acid metabolic process | 4 | 3 |
GO:0009083 | branched-chain amino acid catabolic process | 5 | 3 |
GO:0009987 | cellular process | 1 | 3 |
GO:0016054 | organic acid catabolic process | 4 | 3 |
GO:0019752 | carboxylic acid metabolic process | 5 | 3 |
GO:0043436 | oxoacid metabolic process | 4 | 3 |
GO:0044237 | cellular metabolic process | 2 | 3 |
GO:0044238 | primary metabolic process | 2 | 3 |
GO:0044248 | cellular catabolic process | 3 | 3 |
GO:0044281 | small molecule metabolic process | 2 | 3 |
GO:0044282 | small molecule catabolic process | 3 | 3 |
GO:0046395 | carboxylic acid catabolic process | 5 | 3 |
GO:0071704 | organic substance metabolic process | 2 | 3 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 3 |
GO:1901565 | organonitrogen compound catabolic process | 4 | 3 |
GO:1901575 | organic substance catabolic process | 3 | 3 |
GO:1901605 | alpha-amino acid metabolic process | 4 | 3 |
GO:1901606 | alpha-amino acid catabolic process | 5 | 3 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 22 |
GO:0003860 | 3-hydroxyisobutyryl-CoA hydrolase activity | 6 | 22 |
GO:0016289 | CoA hydrolase activity | 5 | 22 |
GO:0016787 | hydrolase activity | 2 | 22 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 22 |
GO:0016790 | thiolester hydrolase activity | 4 | 22 |
GO:0016853 | isomerase activity | 2 | 8 |
GO:0016829 | lyase activity | 2 | 5 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 28 | 32 | PF00656 | 0.482 |
CLV_NRD_NRD_1 | 106 | 108 | PF00675 | 0.290 |
CLV_NRD_NRD_1 | 67 | 69 | PF00675 | 0.402 |
CLV_PCSK_KEX2_1 | 106 | 108 | PF00082 | 0.290 |
CLV_PCSK_KEX2_1 | 289 | 291 | PF00082 | 0.303 |
CLV_PCSK_KEX2_1 | 332 | 334 | PF00082 | 0.445 |
CLV_PCSK_KEX2_1 | 67 | 69 | PF00082 | 0.402 |
CLV_PCSK_PC1ET2_1 | 289 | 291 | PF00082 | 0.424 |
CLV_PCSK_PC1ET2_1 | 332 | 334 | PF00082 | 0.290 |
CLV_PCSK_PC7_1 | 63 | 69 | PF00082 | 0.402 |
CLV_PCSK_SKI1_1 | 23 | 27 | PF00082 | 0.281 |
CLV_PCSK_SKI1_1 | 77 | 81 | PF00082 | 0.452 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.519 |
DOC_CKS1_1 | 291 | 296 | PF01111 | 0.410 |
DOC_MAPK_gen_1 | 250 | 257 | PF00069 | 0.192 |
DOC_MAPK_HePTP_8 | 90 | 102 | PF00069 | 0.147 |
DOC_MAPK_MEF2A_6 | 93 | 102 | PF00069 | 0.457 |
DOC_PP4_FxxP_1 | 139 | 142 | PF00568 | 0.268 |
DOC_USP7_MATH_1 | 203 | 207 | PF00917 | 0.404 |
DOC_USP7_MATH_1 | 260 | 264 | PF00917 | 0.293 |
DOC_WW_Pin1_4 | 243 | 248 | PF00397 | 0.257 |
DOC_WW_Pin1_4 | 274 | 279 | PF00397 | 0.273 |
DOC_WW_Pin1_4 | 290 | 295 | PF00397 | 0.280 |
DOC_WW_Pin1_4 | 7 | 12 | PF00397 | 0.501 |
LIG_14-3-3_CanoR_1 | 106 | 113 | PF00244 | 0.444 |
LIG_14-3-3_CanoR_1 | 218 | 227 | PF00244 | 0.290 |
LIG_14-3-3_CanoR_1 | 23 | 28 | PF00244 | 0.254 |
LIG_14-3-3_CanoR_1 | 333 | 339 | PF00244 | 0.405 |
LIG_14-3-3_CanoR_1 | 46 | 52 | PF00244 | 0.397 |
LIG_14-3-3_CanoR_1 | 67 | 71 | PF00244 | 0.402 |
LIG_Actin_WH2_2 | 238 | 254 | PF00022 | 0.257 |
LIG_BRCT_BRCA1_1 | 154 | 158 | PF00533 | 0.402 |
LIG_FHA_1 | 152 | 158 | PF00498 | 0.402 |
LIG_FHA_1 | 187 | 193 | PF00498 | 0.274 |
LIG_FHA_1 | 22 | 28 | PF00498 | 0.307 |
LIG_FHA_1 | 267 | 273 | PF00498 | 0.407 |
LIG_FHA_1 | 280 | 286 | PF00498 | 0.330 |
LIG_FHA_2 | 228 | 234 | PF00498 | 0.312 |
LIG_FHA_2 | 296 | 302 | PF00498 | 0.419 |
LIG_FHA_2 | 352 | 358 | PF00498 | 0.467 |
LIG_FHA_2 | 78 | 84 | PF00498 | 0.349 |
LIG_Integrin_RGD_1 | 304 | 306 | PF01839 | 0.402 |
LIG_Integrin_RGD_1 | 63 | 65 | PF01839 | 0.402 |
LIG_LIR_Apic_2 | 136 | 142 | PF02991 | 0.385 |
LIG_LIR_Gen_1 | 155 | 166 | PF02991 | 0.402 |
LIG_LIR_Gen_1 | 195 | 205 | PF02991 | 0.183 |
LIG_LIR_Gen_1 | 306 | 314 | PF02991 | 0.354 |
LIG_LIR_Nem_3 | 155 | 161 | PF02991 | 0.365 |
LIG_LIR_Nem_3 | 189 | 194 | PF02991 | 0.277 |
LIG_LIR_Nem_3 | 195 | 200 | PF02991 | 0.237 |
LIG_LIR_Nem_3 | 306 | 310 | PF02991 | 0.321 |
LIG_PDZ_Class_2 | 357 | 362 | PF00595 | 0.452 |
LIG_PTB_Apo_2 | 85 | 92 | PF02174 | 0.354 |
LIG_SH2_CRK | 307 | 311 | PF00017 | 0.386 |
LIG_SH2_NCK_1 | 307 | 311 | PF00017 | 0.402 |
LIG_SH2_PTP2 | 191 | 194 | PF00017 | 0.402 |
LIG_SH2_SRC | 191 | 194 | PF00017 | 0.271 |
LIG_SH2_STAP1 | 96 | 100 | PF00017 | 0.147 |
LIG_SH2_STAT5 | 169 | 172 | PF00017 | 0.271 |
LIG_SH2_STAT5 | 191 | 194 | PF00017 | 0.256 |
LIG_SH2_STAT5 | 307 | 310 | PF00017 | 0.334 |
LIG_SH2_STAT5 | 48 | 51 | PF00017 | 0.330 |
LIG_SH2_STAT5 | 60 | 63 | PF00017 | 0.295 |
LIG_SH3_3 | 221 | 227 | PF00018 | 0.402 |
LIG_SUMO_SIM_anti_2 | 269 | 274 | PF11976 | 0.341 |
LIG_SUMO_SIM_anti_2 | 345 | 350 | PF11976 | 0.377 |
LIG_SUMO_SIM_par_1 | 23 | 28 | PF11976 | 0.402 |
LIG_SUMO_SIM_par_1 | 268 | 274 | PF11976 | 0.357 |
LIG_SUMO_SIM_par_1 | 281 | 286 | PF11976 | 0.396 |
LIG_TYR_ITSM | 187 | 194 | PF00017 | 0.290 |
LIG_WRC_WIRS_1 | 300 | 305 | PF05994 | 0.290 |
MOD_CDK_SPxxK_3 | 243 | 250 | PF00069 | 0.192 |
MOD_CK1_1 | 10 | 16 | PF00069 | 0.416 |
MOD_CK1_1 | 206 | 212 | PF00069 | 0.241 |
MOD_CK2_1 | 227 | 233 | PF00069 | 0.341 |
MOD_CK2_1 | 295 | 301 | PF00069 | 0.338 |
MOD_CK2_1 | 337 | 343 | PF00069 | 0.344 |
MOD_CK2_1 | 351 | 357 | PF00069 | 0.358 |
MOD_CK2_1 | 77 | 83 | PF00069 | 0.348 |
MOD_Cter_Amidation | 65 | 68 | PF01082 | 0.349 |
MOD_GlcNHglycan | 119 | 122 | PF01048 | 0.424 |
MOD_GlcNHglycan | 2 | 5 | PF01048 | 0.561 |
MOD_GlcNHglycan | 209 | 212 | PF01048 | 0.236 |
MOD_GlcNHglycan | 261 | 265 | PF01048 | 0.274 |
MOD_GSK3_1 | 10 | 17 | PF00069 | 0.381 |
MOD_GSK3_1 | 152 | 159 | PF00069 | 0.402 |
MOD_GSK3_1 | 203 | 210 | PF00069 | 0.221 |
MOD_GSK3_1 | 21 | 28 | PF00069 | 0.281 |
MOD_GSK3_1 | 241 | 248 | PF00069 | 0.260 |
MOD_GSK3_1 | 295 | 302 | PF00069 | 0.369 |
MOD_GSK3_1 | 305 | 312 | PF00069 | 0.377 |
MOD_NEK2_1 | 105 | 110 | PF00069 | 0.290 |
MOD_NEK2_1 | 170 | 175 | PF00069 | 0.274 |
MOD_NEK2_1 | 309 | 314 | PF00069 | 0.198 |
MOD_PIKK_1 | 105 | 111 | PF00454 | 0.290 |
MOD_PIKK_1 | 141 | 147 | PF00454 | 0.290 |
MOD_PKA_2 | 105 | 111 | PF00069 | 0.290 |
MOD_PKA_2 | 66 | 72 | PF00069 | 0.402 |
MOD_Plk_1 | 134 | 140 | PF00069 | 0.402 |
MOD_Plk_1 | 305 | 311 | PF00069 | 0.257 |
MOD_Plk_4 | 152 | 158 | PF00069 | 0.297 |
MOD_Plk_4 | 295 | 301 | PF00069 | 0.349 |
MOD_Plk_4 | 305 | 311 | PF00069 | 0.349 |
MOD_ProDKin_1 | 243 | 249 | PF00069 | 0.257 |
MOD_ProDKin_1 | 274 | 280 | PF00069 | 0.273 |
MOD_ProDKin_1 | 290 | 296 | PF00069 | 0.280 |
MOD_ProDKin_1 | 7 | 13 | PF00069 | 0.484 |
MOD_SUMO_rev_2 | 69 | 79 | PF00179 | 0.402 |
TRG_ENDOCYTIC_2 | 169 | 172 | PF00928 | 0.287 |
TRG_ENDOCYTIC_2 | 191 | 194 | PF00928 | 0.402 |
TRG_ENDOCYTIC_2 | 307 | 310 | PF00928 | 0.379 |
TRG_ER_diArg_1 | 105 | 107 | PF00400 | 0.290 |
TRG_NES_CRM1_1 | 317 | 331 | PF08389 | 0.288 |
TRG_Pf-PMV_PEXEL_1 | 252 | 256 | PF00026 | 0.473 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P500 | Leptomonas seymouri | 64% | 100% |
A0A0N0P5E1 | Leptomonas seymouri | 35% | 98% |
A0A1X0NSC5 | Trypanosomatidae | 41% | 99% |
A0A1X0NTE8 | Trypanosomatidae | 43% | 100% |
A0A1X0NTM5 | Trypanosomatidae | 44% | 100% |
A0A381MRJ9 | Leishmania infantum | 91% | 100% |
A0A3Q8IDG7 | Leishmania donovani | 92% | 100% |
A0A3Q8IHF8 | Leishmania donovani | 37% | 98% |
A0A3Q8ITQ0 | Leishmania donovani | 91% | 100% |
A2VDC2 | Xenopus laevis | 34% | 94% |
A4HL04 | Leishmania braziliensis | 83% | 100% |
A4HL05 | Leishmania braziliensis | 80% | 100% |
A4HL06 | Leishmania braziliensis | 40% | 100% |
A4I8I5 | Leishmania infantum | 92% | 99% |
A4I8I6 | Leishmania infantum | 37% | 98% |
D0AAN2 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 42% | 100% |
E9B3E6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 37% | 98% |
O74802 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 31% | 84% |
P28817 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 28% | 72% |
Q1PEY5 | Arabidopsis thaliana | 28% | 96% |
Q28FR6 | Xenopus tropicalis | 34% | 94% |
Q2HJ73 | Bos taurus | 34% | 94% |
Q4Q4Q4 | Leishmania major | 39% | 100% |
Q4Q4Q5 | Leishmania major | 92% | 100% |
Q4Q4Q6 | Leishmania major | 92% | 100% |
Q55GS6 | Dictyostelium discoideum | 33% | 95% |
Q58EB4 | Danio rerio | 34% | 95% |
Q5XF59 | Arabidopsis thaliana | 33% | 90% |
Q5XIE6 | Rattus norvegicus | 34% | 94% |
Q5ZJ60 | Gallus gallus | 34% | 94% |
Q6NMB0 | Arabidopsis thaliana | 29% | 96% |
Q6NVY1 | Homo sapiens | 34% | 94% |
Q8QZS1 | Mus musculus | 34% | 94% |
Q8RXN4 | Arabidopsis thaliana | 27% | 89% |
Q9LK08 | Arabidopsis thaliana | 29% | 87% |
Q9LKJ1 | Arabidopsis thaliana | 28% | 96% |
Q9SHJ8 | Arabidopsis thaliana | 30% | 94% |
Q9T0K7 | Arabidopsis thaliana | 29% | 86% |
V5BQZ7 | Trypanosoma cruzi | 39% | 94% |